Investors / United States / BioStar Capital
BioStar Capital
Venture capital · Charlevoix, MI, United States · North America
BioStar Capital is a venture capital firm founded in 2005 by cardiologist Dr. Louis A. Cannon that invests in medical technologies. It works with a network of over 100 medical practitioners, including Medical Venture Partners, who evaluate opportunities alongside its financial team and support portfolio companies toward exits.
Invests inHealthcare & Biotech
In its own wordsmedtechcardiologyorthopedicsroboticsmedical deviceshealthcare
Your fit with BioStar Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBioStar Capital lists 5 checked portfolio companies on its own site and is named in 3 funding rounds, 2 of them as lead. Its most frequent entry is Growth, 67% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 80% of its companies are based in United States. It invests most often alongside S3 Ventures, Angelini Ventures and Fountain Healthcare Partners.
Counts come from funding rounds that name BioStar Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 33% |
| Growth | 67% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 2 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 4th | 5 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| S3 Ventures | 2 |
| Angelini Ventures | 1 |
| Fountain Healthcare Partners | 1 |
| Kairos Ventures | 1 |
| MemorialCare Innovation Fund | 1 |
| RA Capital | 1 |
| Santa Cruz Ventures | 1 |
| View Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare BioStar Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with BioStar Capital| Date | Company | Stage |
|---|---|---|
| 8 Oct 2026 | Series C+ Led | |
| 11 Aug 2026 | Series C+ | |
| 1 Jul 2025 | Series B Led |
Round details for BioStar Capital
Amounts, full round histories and every co-investor in BioStar Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
5 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Field Medical develops pulsed field ablation technology for treating cardiac arrhythmias. | Healthcare & Biotech | Jul 2025Series B | Funding round | |
| Foldax develops and manufactures heart valve technology, including the TRIA Mitral Valve | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides robotic microsurgery systems and instruments for surgeons to perform complex procedures with greater precision and control. | Healthcare & Biotech | Oct 2026Series C+ | Funding round | |
| REVA Medical develops and sells implantable medical devices using bioresorbable polymer technologies for vascular applications. | Healthcare & Biotech | Portfolio page | ||
| Versa Vascular is developing a minimally invasive treatment option for patients with severe tricuspid regurgitation | Healthcare & Biotech | Aug 2026Series C+ | Funding round |
About this data
site last read 5 Nov 2026- Site
- biostarcapital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 1 Jul 2025
- Companies checked
- 5
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get BioStar Capital's profile as data
Pull BioStar Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/biostarcapital.com
# also
GET /v1/firms/biostarcapital.com/portfolio
GET /v1/firms/biostarcapital.com/coinvestors
GET /v1/firms/biostarcapital.com/news